Literature DB >> 19098199

Detection of hepatocellular carcinoma in patients with cirrhosis: added value of coronal reformations from isotropic voxels with 64-MDCT.

Daniele Marin1, Carlo Catalano, Gianmaria De Filippis, Michele Di Martino, Antonino Guerrisi, Massimo Rossi, Roberto Passariello.   

Abstract

OBJECTIVE: The purpose of our study was to prospectively assess the added value of isotropic coronal reformations of the liver when using 64-MDCT for the detection of hepatocellular carcinoma (HCC). SUBJECTS AND METHODS: Seventy-one consecutive patients (60 men, 11 women; mean age, 65 years) suspected of having HCC underwent 64-MDCT with coronal reformations. A multiphasic CT protocol that included unenhanced, hepatic arterial, portal venous, and equilibrium phases was performed. Three independent, blinded readers interpreted the transverse scan alone, the coronal scan alone, and the combined transverse and coronal scans for the presence of HCC. Sensitivity, positive predictive value, area under the receiver operating characteristic curve (A(z)), and interpretation time were calculated for each reading session.
RESULTS: Seventy-six HCC nodules were confirmed in 48 patients using histopathologic analysis or follow-up with long-term CT, MRI, or both (mean follow-up time, 12 months; range, 12-15 months) as the reference standard. Mean sensitivity, positive predictive value, and A(z) value for HCC detection were, respectively, 84% (191/228 readings), 91% (191/210 readings), and 0.85 for the transverse scan alone; 83% (189/228 readings), 93% (189/203 readings), and 0.86 for the coronal scan alone; and 87% (198/228 readings), 93% (198/213 readings), and 0.87 for combined interpretation of transverse and coronal scans. No comparisons were statistically significant. Forty-eight false-positive interpretations were recorded (19 for the transverse, 14 for the coronal, and 15 for the combined interpretation sets). The reading session in which combined transverse and coronal scans were available for interpretation showed significantly superior reader confidence for HCC detection as well as longer interpretation times (p<0.05 for both comparisons). The average reading time for the combined interpretation of transverse and coronal image sets (mean, 12.1+/-0.8 minutes) was significantly longer than for the transverse image set (7.4+/-1.5 minutes) or the coronal image set (7.1+/-1.3 minutes) (p<0.01).
CONCLUSION: With 64-MDCT, the addition of isotropic coronal reformations to transverse images significantly improved reader confidence for the detection of HCC, with no statistically significant improvement in sensitivity, positive predictive value, or diagnostic accuracy (as determined by the A(z) value). This improvement comes at the cost of a longer interpretation time.

Entities:  

Mesh:

Year:  2009        PMID: 19098199     DOI: 10.2214/AJR.07.3652

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  8 in total

1.  Subtle pathology detection with multidetector row coronal and sagittal CT reformations in acute head trauma.

Authors:  T Thomas Zacharia; Dan T D Nguyen
Journal:  Emerg Radiol       Date:  2009-10-07

2.  Improved image quality in abdominal CT in patients who underwent treatment for hepatocellular carcinoma with small metal implants using a raw data-based metal artifact reduction algorithm.

Authors:  Keitaro Sofue; Takeshi Yoshikawa; Yoshiharu Ohno; Noriyuki Negi; Hiroyasu Inokawa; Naoki Sugihara; Kazuro Sugimura
Journal:  Eur Radiol       Date:  2016-12-02       Impact factor: 5.315

3.  Use of a Dedicated Server to Perform Coronal and Sagittal Reformations in Trauma Examinations.

Authors:  Jason N Itri; William W Boonn
Journal:  J Digit Imaging       Date:  2010-04-15       Impact factor: 4.056

4.  Combined use of contrast-enhanced intraoperative ultrasonography and a fluorescence navigation system for identifying hepatic metastases.

Authors:  Kazuhisa Uchiyama; Masaki Ueno; Satoru Ozawa; Sigehisa Kiriyama; Yoshinobu Shigekawa; Hiroki Yamaue
Journal:  World J Surg       Date:  2010-12       Impact factor: 3.352

Review 5.  Computed tomography for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.

Authors:  Tin Nadarevic; Vanja Giljaca; Agostino Colli; Mirella Fraquelli; Giovanni Casazza; Damir Miletic; Davor Štimac
Journal:  Cochrane Database Syst Rev       Date:  2021-10-06

6.  Reformatted images improve the detection rate of acute traumatic subdural hematomas on brain CT compared with axial images alone.

Authors:  Timothy J Amrhein; William Mostertz; Maria Gisele Matheus; Genevieve Maass-Bolles; Komal Sharma; Heather R Collins; Peter G Kranz
Journal:  Emerg Radiol       Date:  2016-09-12

7.  Hepatocellular carcinoma in cirrhotic patients: prospective comparison of US, CT and MR imaging.

Authors:  Michele Di Martino; Gianmaria De Filippis; Adriano De Santis; Daniel Geiger; Maurizio Del Monte; Concetta Valentina Lombardo; Massimo Rossi; Stefano Ginanni Corradini; Gianluca Mennini; Carlo Catalano
Journal:  Eur Radiol       Date:  2012-11-18       Impact factor: 5.315

8.  [Diagnosis of and therapy for hepatocellular carcinoma].

Authors:  T F Greten; N P Malek; S Schmidt; J Arends; P Bartenstein; W Bechstein; T Bernatik; M Bitzer; A Chavan; M Dollinger; D Domagk; O Drognitz; M Düx; S Farkas; G Folprecht; P Galle; M Geißler; G Gerken; D Habermehl; T Helmberger; K Herfarth; R T Hoffmann; M Holtmann; P Huppert; T Jakobs; M Keller; J Klempnauer; F Kolligs; J Körber; H Lang; F Lehner; F Lordick; A Lubienski; M P Manns; A Mahnken; M Möhler; C Mönch; P Neuhaus; C Niederau; M Ocker; G Otto; P Pereira; G Pott; J Riemer; K Ringe; U Ritterbusch; E Rummeny; P Schirmacher; H J Schlitt; K Schlottmann; V Schmitz; A Schuler; H Schulze-Bergkamen; D von Schweinitz; D Seehofer; H Sitter; C P Straßburg; C Stroszczynski; D Strobel; A Tannapfel; J Trojan; I van Thiel; A Vogel; F Wacker; H Wedemeyer; H Wege; A Weinmann; C Wittekind; B Wörmann; C J Zech
Journal:  Z Gastroenterol       Date:  2013-11-15       Impact factor: 2.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.